6 assets in Disease Characteristic

Therapeutic assets addressing Disease Characteristic, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Azacitidine Disease Characteristic	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Cytarabine Disease Characteristic	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Daunomycin Disease Characteristic	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Venetoclax Disease Characteristic	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Adrenomedullin Disease Characteristic	Danish Headache Center	N/A	D (30)
68Ga-HTK03149 Disease Characteristic	British Columbia Cancer Agency	N/A	NR ()